Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Raj Kaushal & Mandeep Kaur. (2021) Bio-medical potential of chalcone derivatives and their metal complexes as antidiabetic agents: a review. Journal of Coordination Chemistry 74:4-6, pages 725-742.
Read now
Read now
Tomi K Sawyer, Joe C Wu, Jonathon R Sawyer & Jessie M English. (2013) Protein kinase inhibitors: breakthrough medicines and the next generation. Expert Opinion on Investigational Drugs 22:6, pages 675-678.
Read now
Read now
Articles from other publishers (23)
Caroline Moser, Katherine A. Gosselé, Miroslav Balaz, Lucia Balazova, Carla Horvath, Patricia Künzle, Katarzyna Maria Okreglicka, Fengqi Li, Matthias Blüher, Birgit Stierstorfer, Eva Hess, Thorsten Lamla, Bradford Hamilton, Holger Klein, Heike Neubauer, Christian Wolfrum & Susanne Wolfrum. (2023) FAM3D: A gut secreted protein and its potential in the regulation of glucose metabolism. Peptides 167, pages 171047.
Crossref
Crossref
Ankush KumarBhupinder KumarRohit Bhatia. (2023) Design, Synthesis, Molecular Docking, and Biological Evaluation of Isatin-Based Fused Heterocycles As Epidermal Growth Factor Receptor Inhibitors. ASSAY and Drug Development Technologies 21:5, pages 222-233.
Crossref
Crossref
Denis Amilton dos Santos, Higo Fernando Santos Souza, Ariel M. Silber, Tatiana de Arruda Campos Brasil de Souza & Andréa Rodrigues Ávila. (2023) Protein kinases on carbon metabolism: potential targets for alternative chemotherapies against toxoplasmosis. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Wen Jian, Chun-Mei Wei, Jia-Hui Guan, Chang-Hua Mo, Yu-Tao Xu, Wen-Bo Zheng, Lang Li & Chun Gui. (2020) Association between serum HER2/ErbB2 levels and coronary artery disease: a case–control study. Journal of Translational Medicine 18:1.
Crossref
Crossref
Fan Yang & Chu Wang. (2020) Profiling of post-translational modifications by chemical and computational proteomics. Chemical Communications 56:88, pages 13506-13519.
Crossref
Crossref
Brittany M Duggan, Joseph F Cavallari, Kevin P Foley, Nicole G Barra & Jonathan D Schertzer. (2020) RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice. Endocrinology 161:8.
Crossref
Crossref
Doaa A. Zaky, Walaa Wadie, Wagdy M. Eldehna, Ahmed M. El Kerdawy, Dalaal M. Abdallah & Hanan S. El Abhar. (2020) Modulation of endoplasmic reticulum stress response in gut-origin encephalopathy: Impact of vascular endothelial growth factor receptor-2 manipulation. Life Sciences 252, pages 117654.
Crossref
Crossref
Silvia Lai, Maria Ida Amabile, Sandro Mazzaferro, Anna Paola Mitterhofer, Angelo Mazzarella, Alessandro Galani, Giovanni Imbimbo, Rosario Cianci, Marzia Pasquali & Alessio Molfino. (2020) Effects of sunitinib on endothelial dysfunction, metabolic changes, and cardiovascular risk indices in renal cell carcinoma. Cancer Medicine 9:11, pages 3752-3757.
Crossref
Crossref
Agnieszka Karbownik, Anna Stachowiak, Hanna Urjasz, Katarzyna Sobańska, Agnieszka Szczecińska, Tomasz Grabowski, Joanna Stanisławiak-Rudowicz, Anna Wolc, Edmund Grześkowiak & Edyta Szałek. (2020) The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats. Pharmacological Reports 72:1, pages 254-259.
Crossref
Crossref
Amin Ardestani, Sijia Li, Karthika Annamalai, Blaz Lupse, Shirin Geravandi, Aleksandra Dobrowolski, Shan Yu, Siying Zhu, Tyler D. Baguley, Murali Surakattula, Janina Oetjen, Lena Hauberg-Lotte, Raquel Herranz, Sushil Awal, Delsi Altenhofen, Van Nguyen-Tran, Sean Joseph, Peter G. Schultz, Arnab K. Chatterjee, Nikki Rogers, Matthew S. Tremblay, Weijun Shen & Kathrin Maedler. (2019) Neratinib protects pancreatic beta cells in diabetes. Nature Communications 10:1.
Crossref
Crossref
Mahmoud M. Samaha, Eman Said & Hatem A. Salem. (2019) Nilotinib enhances β-islets integrity and secretory functions in a rat model of STZ-induced diabetes mellitus. European Journal of Pharmacology 860, pages 172569.
Crossref
Crossref
Iram Faqir Muhammad, Yan Borné, Xue Bao, Olle Melander, Marju Orho-Melander, Peter M. Nilsson, Jan Nilsson & Gunnar Engström. (2019) Circulating HER2/ErbB2 Levels Are Associated With Increased Incidence of Diabetes: A Population-Based Cohort Study. Diabetes Care 42:8, pages 1582-1588.
Crossref
Crossref
Kahlile Abboud, Sabrina Reis, Maria Martelli, Olivia Zordão, Fabiana Tannihão, Alessandra de Souza, Heloisa Assalin, Dioze Guadagnini, Guilherme Rocha, Mario Saad & Patricia Prada. (2019) Oral Glutamine Supplementation Reduces Obesity, Pro-Inflammatory Markers, and Improves Insulin Sensitivity in DIO Wistar Rats and Reduces Waist Circumference in Overweight and Obese Humans. Nutrients 11:3, pages 536.
Crossref
Crossref
Sarah Akbib, Jordy Stichelmans, Geert Stangé, Zhidong Ling, Zerihun Assefa & Karine H. Hellemans. (2019) Glucocorticoids and checkpoint tyrosine kinase inhibitors stimulate rat pancreatic beta cell proliferation differentially. PLOS ONE 14:2, pages e0212210.
Crossref
Crossref
Kristine Deano Abueg. (2017) Interprofessional Management of Toxicities Related to Cancer Precision Medicine. Seminars in Oncology Nursing 33:4, pages 376-383.
Crossref
Crossref
Bruno Martino, Corrado Mammì, Claudia Labate, Silvia Rodi, Domenica Ielo, Manuela Priolo, Maurizio Postorino, Giovanni Tripepi, Francesca Ronco, Carmelo Laganà, Caterina Musolino, Marianna Greco, Giorgio La Nasa & Giovanni Caocci. (2017) Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib. Experimental Hematology 55, pages 71-75.
Crossref
Crossref
Z. Orfi, F. Waczek, F. Baska, I. Szabadkai, R. Torka, J. Hartmann, L. Orfi & A. Ullrich. (2017) Novel members of quinoline compound family enhance insulin secretion in RIN-5AH beta cells and in rat pancreatic islet microtissue. Scientific Reports 7:1.
Crossref
Crossref
Xiang Li, Jonathan T. Cox, Weiliang Huang, Maureen Kane, Keqi Tang & Charles J. Bieberich. (2016) Quantifying Kinase-Specific Phosphorylation Stoichiometry Using Stable Isotope Labeling In a Reverse In-Gel Kinase Assay. Analytical Chemistry 88:23, pages 11468-11475.
Crossref
Crossref
Agnieszka Karbownik, Edyta Szałek, Katarzyna Sobańska, Tomasz Grabowski, Anna Wolc & Edmund Grześkowiak. (2016) The alteration of pharmacokinetics of erlotinib and OSI420 in type 1 diabetic rabbits. Pharmacological Reports 68:5, pages 964-968.
Crossref
Crossref
Kelly N. Chuh, Anna R. Batt & Matthew R. Pratt. (2016) Chemical Methods for Encoding and Decoding of Posttranslational Modifications. Cell Chemical Biology 23:1, pages 86-107.
Crossref
Crossref
Nehal Mohsen Elsherbiny, Mohamed El-Sherbiny & Eman Said. (2015) Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib. Journal of Physiology and Biochemistry 71:4, pages 635-648.
Crossref
Crossref
Athanasios Fountas, Leonidas-Nikolaos Diamantopoulos & Agathocles Tsatsoulis. (2015) Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?. Trends in Endocrinology & Metabolism 26:11, pages 643-656.
Crossref
Crossref
Anna M Czarnecka, Maciej Kawecki, Fei Lian, Jan Korniluk & Cezary Szczylik. (2015) Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience. Future Oncology 11:16, pages 2267-2282.
Crossref
Crossref